How a big biotech’s start-up gamble went wrong
The Story of Money28 Juni 2023

How a big biotech’s start-up gamble went wrong

Illumina, the world’s biggest gene sequencing company, announced plans to buy cancer detection start-up Grail for $8bn while the biotech boom was in full swing. To Illumina, Grail looked like a potential gold mine. Until reality — and regulators — entered the picture. Three years and an activist investor campaign waged by Carl Icahn later, the FT’s US pharmaceutical correspondent Jamie Smyth explains the problems that have cropped up and what it means for both companies and their shareholders.


Clips from Illumina Inc / Seeking Alpha, Yahoo

- - - - - - - - - - - - - - - - - - - - - - - - - -

For further reading:

Carl Icahn takes aim at genome sequencer Illumina over Grail deal

Has Illumina taken the wrong path in its Grail quest?

Quick blood tests to spot cancer: will they help or harm patients?

- - - - - - - - - - - - - - - - - - - - - - - - - -

On Twitter, follow Jamie Smyth (@JamieSmythF) and Michela Tindera (@mtindera07)


Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

Avsnitt(319)

Introducing: The Story of Money

Introducing: The Story of Money

The economist John Kenneth Galbraith once quipped that “there can be few fields of human endeavour in which history counts for so little as in the world of finance.” This show sets out to prove the op...

15 Apr 1min

Finale: The collapse of India’s $22bn tech star

Finale: The collapse of India’s $22bn tech star

For our final episode: Education start-up Byju’s quickly became the pride of India during the Covid-19 pandemic. But almost as fast as the company rose, it collapsed. The fallout has already resulted ...

1 Apr 31min

Private credit’s public reckoning

Private credit’s public reckoning

After years of fast-paced growth, private credit is facing intense scrutiny. In recent months, investors have made requests to withdraw billions of dollars from the $2tn sector’s funds. The FT’s US pr...

25 Mars 27min

Best of: How the diamond industry lost its sparkle

Best of: How the diamond industry lost its sparkle

This week, we are revisiting a favorite episode. The natural diamond industry is facing an existential threat: lab-grown diamonds. They are chemically and physically identical to natural stones but th...

18 Mars 23min

Introducing Untold: Opus Dei

Introducing Untold: Opus Dei

Introducing Opus Dei, a new season of Untold from the Financial Times. Host Antonia Cundy uncovers the cultural and political influence of a controversial Catholic organisation in America. Opus Dei ex...

13 Mars 1min

Wall Street and crypto battle over the future of money

Wall Street and crypto battle over the future of money

US President Donald Trump handed crypto companies a huge win last year when he signed a piece of legislation to regulate an important part of the digital currency world: stablecoins. But ever since th...

11 Mars 19min

Vote for Behind the Money in the NYC Podcast Awards!

Vote for Behind the Money in the NYC Podcast Awards!

Behind the Money has been nominated for an NYC Podcast Award in the Best Interview Podcast category. It’s an Audience Choice award, which means we need your help to win. Vote for us here. And while yo...

9 Mars 39s

Co-creators Mickey Down & Konrad Kay on ‘Industry’

Co-creators Mickey Down & Konrad Kay on ‘Industry’

This week Michela and the FT’s US banking editor, Joshua Franklin, interview the co-creators of the hit television show, Industry. In its fourth season, the show follows the lives of ambitious young p...

4 Mars 31min

Populärt inom Business & ekonomi

framgangspodden
varvet
badfluence
rss-jossan-nina
rss-svart-marknad
svd-tech-brief
rss-borsens-finest
uppgang-och-fall
bathina-en-podcast
rss-dagen-med-di
rss-kort-lang-analyspodden-fran-di
rss-inga-dumma-fragor-om-pengar
avanzapodden
lastbilspodden
fill-or-kill
borsmorgon
24fragor
tabberaset
rikatillsammans-om-privatekonomi-rikedom-i-livet
montrosepodden